Todd Philip Knutson

13PUBLICATIONS
44CO-AUTHORS
Molecular targetsTumour immunologyPredictive and prognostic markersMedical devicesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jan 26, 2026
Evolution of AR and Non-AR Alterations in ctDNA of Patients with Metastatic Prostate Cancer Treated in the Phase III Alliance A031201 Trial.

José C Valentín López, Chenxi Yu, Todd P Knutson

|Sep 04, 2025
Leukemia escapes immunity by imposing a type 1 regulatory program on neoantigen-specific CD4+ T cells.

Hrishi Venkatesh, Enoc Granados Centeno, Qianyun Luo

|Dec 11, 2024
AR alterations inform circulating tumor DNA detection in metastatic castration resistant prostate cancer patients.

Todd P Knutson, Bin Luo, Anna Kobilka

|May 15, 2023
Receptor for hyaluronan-mediated motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients.

Sarah E Tarullo, Yuyu He, Claire Daughters

|Nov 01, 2022
Nuclear corepressors NCOR1/NCOR2 regulate B cell development, maintain genomic integrity and prevent transformation.

Robin D Lee, Todd P Knutson, Sarah A Munro

|Mar 11, 2022
Combining nilotinib and PD-L1 blockade reverses CD4+ T-cell dysfunction and prevents relapse in acute B-cell leukemia.

Sean I Tracy, Hrishi Venkatesh, Can Hekim

Pageof 3

Frequent Collaborators

3 joint publications

Andrew C Nelson

3 joint publications

Michael A Farrar

2 joint publications

Nicholas J Brady

2 joint publications

James B McCarthy